CD&R Makes Increased £2.8B Bid For UDG Healthcare
Clayton Dubilier & Rice is raising its offer for health care advisory and pharmaceutical services business UDG to roughly £2.8 billion ($3.9 billion), the companies said Tuesday, and two of the...To view the full article, register now.
Already a subscriber? Click here to view full article